Stephen L Sabba
Director · 4 filings · Latest: Jun 16, 2026
LIGAND PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LGND | Stephen L Sabba | Director | Jun 16, 2026 | Sale | $254.00 | 2,145 | $544.8K | 33,629 | |
LGND | Stephen L Sabba | Director | Jun 16, 2026 | Option Exercise | $66.13 | 2,145 | $141.8K | 35,774 | |
LGND | STEPHEN L. SABBA | — | Jun 16, 2026 | Proposed Sale | $254.00 | 2,145 | $544.8K | — | |
LGND | Stephen L Sabba | Director | Mar 23, 2026 | Sale | $207.87 | 1,000 | $207.9K | 32,793 | |
LGND | STEPHEN L. SABBA | — | Mar 23, 2026 | Proposed Sale | $207.87 | 1,000 | $207.9K | — | |
LGND | Stephen L Sabba | Director | Mar 3, 2026 | Sale | $201.50 | 2,034 | $409.9K | 33,793 | |
LGND | Stephen L Sabba | Director | Mar 3, 2026 | Option Exercise | $69.51 | 2,034 | $141.4K | 35,827 | |
LGND | STEPHEN L. SABBA | — | Mar 3, 2026 | Proposed Sale | $201.50 | 2,034 | $409.9K | — | |
LGND | Sabba Stephen L | — | Mar 18, 2025 | Proposed Sale | $106.00 | 2,406 | $255.0K | — |